by Elec23 | Feb 24, 2025 | News&events
VisMederi has expanded its testing portfolio with cutting-edge pseudo-viral platforms, which are critical tools for examining immunogenicity and developing vaccines against emerging infections. These new technologies enable us to test immune responses in a safe and...
by Elec23 | Feb 12, 2025 | News&events
According to Save the Children’s data collected in the Istat 2024 study, in Italy, just 16.8% of women aged 25 to 34 with a degree in STEM subjects (science, technology, engineering, and mathematics) are employed, compared to 37% of men. In this context,...
by Elec23 | Feb 4, 2025 | News&events
VisMederi Group believes that successful studies are founded on good partnerships. We are happy to work with Bioclass, Unitech, and Accurange, three firms that play critical roles in supporting our operations and growth. Bioclass is a reliable partner for consulting,...
